447 related articles for article (PubMed ID: 34683425)
1. Virulence Potential and Treatment Options of Multidrug-Resistant (MDR)
Kumar S; Anwer R; Azzi A
Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683425
[No Abstract] [Full Text] [Related]
2. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
3. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
Dehbanipour R; Ghalavand Z
J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
5. Biology of
Lee CR; Lee JH; Park M; Park KS; Bae IK; Kim YB; Cha CJ; Jeong BC; Lee SH
Front Cell Infect Microbiol; 2017; 7():55. PubMed ID: 28348979
[No Abstract] [Full Text] [Related]
6. Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection.
Sheldon JR; Himmel LE; Kunkle DE; Monteith AJ; Maloney KN; Skaar EP
PLoS Pathog; 2022 Sep; 18(9):e1010809. PubMed ID: 36054235
[TBL] [Abstract][Full Text] [Related]
7. Insights into
Ayoub Moubareck C; Hammoudi Halat D
Antibiotics (Basel); 2020 Mar; 9(3):. PubMed ID: 32178356
[TBL] [Abstract][Full Text] [Related]
8. Carbapenemases: Transforming
Ramirez MS; Bonomo RA; Tolmasky ME
Biomolecules; 2020 May; 10(5):. PubMed ID: 32384624
[No Abstract] [Full Text] [Related]
9. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
[TBL] [Abstract][Full Text] [Related]
10. Recent perspectives on the virulent factors and treatment options for multidrug-resistant
Skariyachan S; Taskeen N; Ganta M; Venkata Krishna B
Crit Rev Microbiol; 2019 May; 45(3):315-333. PubMed ID: 31012772
[No Abstract] [Full Text] [Related]
11. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
[TBL] [Abstract][Full Text] [Related]
12. Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome.
Brotfain E; Borer A; Koyfman L; Saidel-Odes L; Frenkel A; Gruenbaum SE; Rosenzweig V; Zlotnik A; Klein M
J Intensive Care Med; 2017 Oct; 32(9):528-534. PubMed ID: 26902255
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Litwin A; Fedorowicz O; Duszynska W
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
[No Abstract] [Full Text] [Related]
14. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
16. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Kempf M; Rolain JM
Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
[TBL] [Abstract][Full Text] [Related]
17. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
[TBL] [Abstract][Full Text] [Related]
18. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
Schafer JJ; Goff DA; Stevenson KB; Mangino JE
Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
[TBL] [Abstract][Full Text] [Related]
19. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
Maragakis LL; Perl TM
Clin Infect Dis; 2008 Apr; 46(8):1254-63. PubMed ID: 18444865
[TBL] [Abstract][Full Text] [Related]
20. Ventilator-Associated Pneumonia due to Drug-Resistant
Čiginskienė A; Dambrauskienė A; Rello J; Adukauskienė D
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
